FindTrial
Sign In

Homoeopathic medicine in prediabetic patients

Characterization and assesment of antidiabetic activity of Boerhaavia diffusa Q in pre diabetic subjects-A randomized double blind placebo controlled study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/058209
Enrollment
60
Registered
2023-10-03
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E109- Type 1 diabetes mellitus without complications

Interventions

Intervention1: Homoeopathic medicine: one group will be given placebo and another group will be given Homeopathic medicine Intervention2: Boerhaavia diffusa Q: After doing the screening test,60 subjec

Sponsors

Nisha gopinath
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients fulfilling prediabetic diagnostic criteria, who are not taking any other diabetic medications

Exclusion criteria

Exclusion criteria: Patients with other systemic disorders and under other medications • Patients having the HbA1c value above 7% • Patients with mental disorders • Pregnant women

Design outcomes

Primary

MeasureTime frame
Data on functional and structural groups present in Homoeopathic medicine Boerhaavia diffusa .Q • Available compounds in Boerhaavia diffusa Q if any will be done computational study through Bioinformatic software. • Confirmation of anti diabetic activity of Boerhaavia diffusa Q through invitro studiesTimepoint: Out come will be assessed every 2 weeks.—

Secondary

MeasureTime frame
Clinical data on antidiabetic efficacy of Boerhaavia diffusa Q in subjects with type 2 pre diabeteTimepoint: 2nd year—

Countries

India

Contacts

Public ContactRachana Mol

Sarada Krishna Homeopathic Medical College

drnvsugathan@gmail.com9443558786

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026